Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Rigat

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|April 27, 2026
Mind the gap: Bayesian equipoise calibration of clinical trial designsFabio Rigat
Pharmaceutical Statistics|September 26, 2023
A conservative approach to leveraging external evidence for effective clinical trial designFabio Rigat
Vaccine|December 27, 2016
Core values for vaccine evaluationJames Kenneth Timmis, Fabio Rigat, Rino Rappuoli
Journal of Biopharmaceutical Statistics|July 18, 2022
What is the expected benefit of patient-centric clinical development in oncology?Alessandra Serra, Pavel Mozgunov, Thomas Jaki, et al.
BMC Medical Research Methodology|March 30, 2022
Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studiesAlane Izu, Gaurav Kwatra, Shabir A Madhi, et al.
Pharmaceutical Statistics|February 18, 2015
Threshold-free estimation of functional antibody titers of a group B streptococcus opsonophagocytic killing assayLuca Moraschini, Irene Passalacqua, Monica Fabbrini, et al.
Statistics in Medicine|December 16, 2011
A hybrid procedure for detecting global treatment effects in multivariate clinical trials: theory and applications to fMRI studiesGiorgos Minas, Fabio Rigat, Thomas E Nichols, et al.
Microbial Biotechnology|March 1, 2017
Microbiome yarns: microbiomology of curly and straight hairKenneth Timmis, Franziska Jebok, Fabio Rigat, et al.
Vaccine|January 28, 2014
Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccineChiara Tani, Maria Stella, Danilo Donnarumma, et al.
Vaccine|August 20, 2013
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverageGiacomo Frosi, Alessia Biolchi, Morena Lo Sapio, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|April 27, 2026
Mind the gap: Bayesian equipoise calibration of clinical trial designsFabio Rigat
Pharmaceutical Statistics|September 26, 2023
A conservative approach to leveraging external evidence for effective clinical trial designFabio Rigat
Vaccine|December 27, 2016
Core values for vaccine evaluationJames Kenneth Timmis, Fabio Rigat, Rino Rappuoli
Journal of Biopharmaceutical Statistics|July 18, 2022
What is the expected benefit of patient-centric clinical development in oncology?Alessandra Serra, Pavel Mozgunov, Thomas Jaki, et al.
BMC Medical Research Methodology|March 30, 2022
Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studiesAlane Izu, Gaurav Kwatra, Shabir A Madhi, et al.
Pharmaceutical Statistics|February 18, 2015
Threshold-free estimation of functional antibody titers of a group B streptococcus opsonophagocytic killing assayLuca Moraschini, Irene Passalacqua, Monica Fabbrini, et al.
Statistics in Medicine|December 16, 2011
A hybrid procedure for detecting global treatment effects in multivariate clinical trials: theory and applications to fMRI studiesGiorgos Minas, Fabio Rigat, Thomas E Nichols, et al.
Microbial Biotechnology|March 1, 2017
Microbiome yarns: microbiomology of curly and straight hairKenneth Timmis, Franziska Jebok, Fabio Rigat, et al.
Vaccine|January 28, 2014
Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccineChiara Tani, Maria Stella, Danilo Donnarumma, et al.
Vaccine|August 20, 2013
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverageGiacomo Frosi, Alessia Biolchi, Morena Lo Sapio, et al.
Pageof 2